文献速递免疫规划

减量猫用疫苗的安全性与免疫原性评估

Evaluation of safety and immunogenicity of feline vaccines with reduced volume.
PubMed 文献 · Vaccine · 2021-01-20

研究评估了0.5 ml减量猫用疫苗(含与常规1 ml相同抗原量)的安全性与免疫原性。实验室小规模试验及398只猫的随机对照现场试验显示,0.5 ml疫苗耐受良好,局部事件更少,免疫原性与1 ml疫苗相当。

要点

  • 0.5 ml减量疫苗与1 ml常规疫苗抗原含量相同。
  • 398只猫随机对照现场试验评估安全性。
  • 减量疫苗局部事件更少,免疫原性相当。

核心结论

  • 0.5 ml减量猫用疫苗耐受良好,局部事件少于1 ml疫苗,免疫原性相当。

研究设计与样本

  • 实验室小规模安全性试验及398只猫的随机对照现场试验,监测即时和延迟局部与全身不良事件。

主要发现

  • 0.5 ml疫苗在猫中耐受良好,诱导的局部事件少于1 ml疫苗。
  • 0.5 ml疫苗的免疫原性与对应的1 ml疫苗相同。

临床怎么用

  • 减少疫苗体积可提高接种便利性,有助于遵循接种指南以减少免疫接种后不良事件的发生率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A non adjuvanted vaccine against feline herpesvirus, feline calicivirus, feline panleucopenia and feline leukemia has been formulated in reduced volume (0.5 ml) with the same antigen content as the conventional 1 ml presentation. This paper reports studies evaluating the safety and the immunogenicity of this reduced volume vaccine in comparison with the conventional volume vaccine. The safety of both vaccines was evaluated in a small sized laboratory trial. It was further tested in a randomized controlled field trial on a total of 398 cats. Immediate and delayed local and systemic adverse events were monitored after vaccination. The immunogenicity of each vaccine was also checked by serological antibody responses against the vaccines antigens during the laboratory trial. These studies showed that the 0.5 ml vaccine was well tolerated in cats, inducing less local events, while keeping the same immunogenicity as the corresponding 1 ml vaccine. Reducing the volume of the vaccine is a way to improve the convenience of administration and to help following vaccination guidelines with the aim of reducing the incidence of adverse events following vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Jas D, Frances-Duvert V, Brunet S, et al. Evaluation of safety and immunogenicity of feline vaccines with reduced volume. Vaccine. 2021. PMID: 33485645. doi:10.1016/j.vaccine.2021.01.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。